Executive Summary
A surge of 76 8-K filings on December 29, 2025, reveals acute corporate distress across US public companies, dominated by entry into material definitive agreements (Item 1.01 in ~70% of filings), likely emergency financings or restructurings, alongside clusters of delistings (Item 3.01, 8+ cases), bankruptcies/receiverships (Item 1.03, 2 cases), and agreement terminations (Item 1.02, 5 cases). This unprecedented single-day volume signals systemic pressure on micro/small-cap firms, particularly in biotech/pharma and niche tech/manufacturing, amplifying liquidity risks and dilution via unregistered equity sales (Item 3.02 frequent). Portfolio managers should de-risk exposures to distressed names while eyeing short opportunities amid broader market volatility.
Tracking the trend? Catch up on the prior US Corporate Distress Financial Stress SEC Filings digest from December 22, 2025.
Investment Signals(5)
- ▲
Multiple delistings and transfer to OTC markets erode liquidity and valuation [BEARISH] - DYADIC INTERNATIONAL INC, Silo Pharma, Vivakor, Fly-E Group, UWM Holdings, Abacus Global, Noodles & Co
- ▲
Bankruptcy/receivership filings confirm insolvency trajectories [BEARISH] - Clearside Biomedical, ModivCare Inc
- ▲
Terminations of material agreements disrupt strategies/financings [BEARISH] - Vaxart, Heritage Distilling, Verisk Analytics, Arcadia Biosciences
- ▲
Material impairments signal asset write-downs [BEARISH] - ImmuCell Corp
- ▲
Material cybersecurity incident raises litigation/operational risks [BEARISH] - Coupang
Risk Flags(4)
- ▼
Cluster of 8+ delistings indicates widespread non-compliance with exchange standards, potentially cascading to reduced institutional access and price collapses
- ▼
Two explicit bankruptcy proceedings (Clearside, ModivCare) with accompanying control changes/control shifts highlight acute insolvency contagion risks in healthcare/biotech
- ▼
Prevalent unregistered equity sales (20+ filings) and new financial obligations (Item 2.03, 25+ cases) point to aggressive dilution and leverage buildup amid cash crunches
- ▼
Lack of disclosure details across 90%+ of MDAs obscures true financial impacts, elevating hidden leverage or toxic financing risks
Opportunities(4)
- ◆
Short delisting/bankruptcy candidates for rapid downside (e.g., Clearside, ModivCare, Silo Pharma) as liquidity dries up and OTC trading discounts apply
- ◆
Distressed debt plays in frequent Item 2.03 filers (e.g., loanDepot, Orion Group) where new obligations may offer high-yield entry pre-restructuring
- ◆
Long volatility/hedges on micro-cap biotech basket given concentration of distress signals (Vaxart, Dynavax, Tonix) versus broader market
- ◆
Monitor MDA outcomes for turnaround alpha in neutral filings (e.g., Sidus Space, ImmunityBio) if exhibits reveal non-dilutive partnerships
Sector Themes(3)
- Biotech/pharma distress wave◆
10+ filings (e.g., Clearside bankruptcy, Dyadic delisting, Vaxart termination) driven by funding droughts, impairments, and delistings amid clinical/trial risks
- Financing desperation in small caps◆
Overwhelming Item 1.01/2.03/3.02 combos signal equity/debt raises to stave off insolvency, correlating with governance shifts (5.02/5.03)
- Exchange compliance failures◆
Multi-sector delistings (tech, holdings, food) reflect broader micro-cap liquidity crisis and regulatory scrutiny
Watch List(4)
- 👁
Clearside Biomedical & ModivCare Inc - Bankruptcy proceedings may trigger creditor auctions or equity wipes
- 👁
Delisting cluster (DYADIC, Silo Pharma, UWM Holdings, Noodles) - Monitor OTC transitions for further downside or buyout catalysts
- 👁
High-volume MDA filers (Orion Group, loanDepot, Bausch Health) - Exhibits may reveal restructuring terms with portfolio implications
- 👁
Coupang cybersecurity incident - Potential follow-on 8-Ks on remediation costs, lawsuits, or revenue hits
Filing Analyses(76)
29-12-2025
The filer submitted an 8-K on December 29, 2025 (AccNo: 0001539497-25-003346, Size: 6 MB) reporting entry into a Material Definitive Agreement under Item 1.01, with Financial Statements and Exhibits under Item 9.01. Event Type: Material Event, Date: December 29, 2025, Source: us_sec. No details on the agreement, parties, transaction value, or financial impacts are disclosed in the provided filing summary; sector not specified.
29-12-2025
Sidus Space Inc. filed a Form 8-K on December 29, 2025 (AccNo: 0001493152-25-029229, Size: 983 KB), reporting Item 1.01 (Entry into a Material Definitive Agreement), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no further details provided on the nature of the agreement, events, or exhibits. Sector not specified.
29-12-2025
Brand Engagement Network Inc. filed a Form 8-K on 2025-12-29 (AccNo: 0001493152-25-029157, Size: 222 KB) reporting under Item 1.01 Entry into a Material Definitive Agreement and under Item 9.01 Financial Statements and Exhibits. This is a multi-item filing for a material event. Sector not specified.
29-12-2025
Trio Petroleum Corp filed a Form 8-K on December 29, 2025 (AccNo: 0001493152-25-029158, size 273 KB), reporting entry into a material definitive agreement (Item 1.01), unregistered sales of equity securities (Item 3.02), and financial statements and exhibits (Item 9.01). This is a multi-item filing classified as a Material Event from US SEC source. No details on transaction value, parties, financial impact, or sector are disclosed.
29-12-2025
Orion Group Holdings Inc filed a Form 8-K on December 29, 2025 (AccNo: 0001402829-25-000065), reporting entry into a material definitive agreement (Item 1.01), termination of a material definitive agreement (Item 1.02), creation of a direct financial obligation or off-balance sheet arrangement (Item 2.03), material modifications to rights of security holders (Item 3.03), Regulation FD disclosure (Item 7.01), and financial statements and exhibits (Item 9.01). This is a multi-item filing with no specific transaction details, dollar values, parties, or quantitative impacts disclosed in the provided information.
29-12-2025
Dyadic International Inc filed an 8-K on December 29, 2025 (AccNo: 0001493152-25-029141, Size: 226 KB) under Item 3.01, disclosing a notice of delisting or failure to satisfy a continued listing rule or standard, or transfer of listing. No additional details on the core event, financial impacts, transaction values, or reasons for delisting are provided. Sector is not specified.
29-12-2025
Vaxart, Inc. filed an 8-K on December 29, 2025 (AccNo: 0001437749-25-038774, Size: 155 KB) disclosing under Item 1.02 the termination of a material definitive agreement. No details on the agreement's parties, value, strategic role, or financial impacts are provided. Sector not specified.
29-12-2025
loanDepot, Inc. filed a Form 8-K on December 29, 2025 (AccNo: 0001831631-25-000264, Size: 2 MB), reporting under Item 1.01 Entry into a Material Definitive Agreement, Item 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement, and Item 9.01 Financial Statements and Exhibits. This is a multi-item mandatory disclosure of a material event, but specific details of the agreement, obligation, dollar value, or other terms are NOT_DISCLOSED in the provided summary. Sector is not specified.
29-12-2025
NextTrip, Inc. filed a Form 8-K on December 29, 2025 (AccNo: 0001493152-25-029151, Size: 58 MB), reporting multiple items including Item 1.01 (Entry into a Material Definitive Agreement), Item 3.02 (Unregistered Sales of Equity Securities), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). No specific details on transaction values, parties involved, financial impacts, or quantitative metrics are disclosed in the provided filing summary. This is a multi-item mandatory filing as a material event.
29-12-2025
Company filed Form 8-K on 2025-12-29 (AccNo: 0001104659-25-124353, Size: 2 MB) reporting Item 1.01 (Entry into a Material Definitive Agreement), Item 2.03 (Creation of a Direct Financial Obligation or an Off-Balance Sheet Arrangement), and Item 9.01 (Financial Statements and Exhibits). Event dated December 29, 2025. No specific transaction details, amounts, parties, or financial metrics disclosed in provided filing summary.
29-12-2025
ImmunityBio, Inc. filed a Form 8-K on December 29, 2025 (AccNo: 0001193125-25-331244, Size: 188 KB) reporting entry into a material definitive agreement under Item 1.01, other events under Item 8.01, and financial statements and exhibits under Item 9.01. This is a multi-item filing with no specific details on the agreement, events, or financials provided in the summary. Sector not specified.
29-12-2025
Eve Holding, Inc. filed a Form 8-K on December 29, 2025 (AccNo: 0001554855-25-002333, Size: 750 KB), disclosing under Item 1.01 entry into a material definitive agreement and under Item 2.03 creation of a direct financial obligation or an obligation under an off-balance sheet arrangement. Item 9.01 provides financial statements and exhibits. No transaction details, dollar values, counterparties, or other specifics are stated in the provided filing summary.
29-12-2025
Clearside Biomedical, Inc. filed a Form 8-K on December 29, 2025 (AccNo: 0001193125-25-332152, Size: 3 MB), reporting bankruptcy or receivership under Item 1.03, other events under Item 8.01, and financial statements/exhibits under Item 9.01. No specific details on the bankruptcy proceedings, financial impacts, or transaction values are disclosed in the provided filing summary. Sector not specified.
29-12-2025
Undisclosed company filed an 8-K on December 29, 2025 (AccNo: 0001628280-25-058806, Size: 86 MB) reporting under Items 1.01 (Entry into a Material Definitive Agreement), 2.03 (Creation of a Direct Financial Obligation or Off-Balance Sheet Arrangement), 3.02 (Unregistered Sales of Equity Securities), and 9.01 (Financial Statements and Exhibits). This is a multi-item mandatory disclosure of a material event, filed on the event date, likely within the required 4-business-day window. No specific details on transaction value, parties, financial impacts, or strategic context are provided.
29-12-2025
Target Hospitality Corp. filed a Form 8-K on December 29, 2025 (AccNo: 0001104659-25-124455, size 1 MB), reporting under Item 1.01 entry into a material definitive agreement and under Item 9.01 financial statements and exhibits. This is a multi-item filing disclosing a core material event without specific details on the agreement, transaction value, or exhibits provided in the available summary. Sector not specified.
29-12-2025
Immersion Corp filed a Form 8-K on December 29, 2025 (AccNo: 0001193125-25-332643), reporting under Item 3.01 a Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. Item 9.01 discloses Financial Statements and Exhibits. No specific details on delisting reasons, transaction values, financial impacts, or other quantitative data are provided.
29-12-2025
Bausch Health Companies Inc. filed a Form 8-K on December 29, 2025 (AccNo: 0000885590-25-000059, Size: 264 KB), reporting under Item 1.01 entry into a material definitive agreement and under Item 2.03 creation of a direct financial obligation or an obligation under an off-balance sheet arrangement of the registrant. Item 9.01 discloses financial statements and exhibits. No specific transaction details, values, parties, or other quantitative data are provided in the filing summary.
29-12-2025
TGE Value Creative Solutions Corp filed a Form 8-K on December 29, 2025 (AccNo: 0001213900-25-125808, Size: 2 MB), reporting multiple items: Entry into a Material Definitive Agreement (Item 1.01), Unregistered Sales of Equity Securities (Item 3.02), Amendments to Articles of Incorporation or Bylaws/Change in Fiscal Year (Item 5.03), Other Events (Item 8.01), and Financial Statements and Exhibits (Item 9.01). This is a multi-item mandatory filing for specified events, but specific details on the core transaction, dollar values, share counts, or financial impacts are NOT_DISCLOSED in the provided information. Sector is not specified.
29-12-2025
ALEXANDERS INC filed an 8-K on December 29, 2025 (AccNo: 0000003499-25-000038, Size: 186 KB), reporting under Item 1.01 (Entry into a Material Definitive Agreement) and Item 2.03 (Creation of a Direct Financial Obligation or Off-Balance Sheet Arrangement), with Item 9.01 (Financial Statements and Exhibits). No specific details on the agreement, transaction value, terms, or financial metrics are provided in the summary. Sector not specified.
29-12-2025
ImmuCell Corporation (/DE/) filed a Form 8-K on December 29, 2025 (AccNo: 0001437749-25-038773, size 190 KB), reporting under Item 2.06 Material Impairments, Item 8.01 Other Events, and Item 9.01 Financial Statements and Exhibits. This is a multi-item mandatory filing disclosing material impairments and other events, but specific details on the core event, dollar values, financial impacts, or transaction sizes are NOT_DISCLOSED in the provided summary. No quantitative financial metrics, named entities beyond the filer, or additional context are available.
29-12-2025
QHSLab, Inc. filed a Form 8-K on December 29, 2025 (AccNo: 0001493152-25-029222, Size: 439 KB), reporting Items 1.01 (Entry into a Material Definitive Agreement), 3.02 (Unregistered Sales of Equity Securities), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific transaction details, dollar values, share counts, or financial metrics disclosed in the provided summary. Sector is not specified.
29-12-2025
Tron Inc. filed a Form 8-K on December 29, 2025 (AccNo: 0001493152-25-029225, Size: 309 KB), reporting multiple items including Item 1.01 (Entry into a Material Definitive Agreement), Item 3.02 (Unregistered Sales of Equity Securities), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific details on the agreement, sales, transaction value, parties, or financial impacts disclosed in the provided summary. Sector not specified.
29-12-2025
Verisk Analytics, Inc. filed a Form 8-K on December 29, 2025 (AccNo: 0001193125-25-332544, Size: 166 KB), disclosing under Item 1.02 the termination of a material definitive agreement, Item 7.01 Regulation FD Disclosure, Item 8.01 Other Events, and Item 9.01 Financial Statements and Exhibits. No specific details on the terminated agreement, transaction values, financial impacts, or other quantitative data are provided in the filing summary. Sector is not specified.
29-12-2025
Heritage Distilling Holding Company, Inc. filed a Form 8-K on December 29, 2025 (AccNo: 0001493152-25-029232), reporting the termination of a material definitive agreement under Item 1.02, Regulation FD Disclosure under Item 7.01, and Financial Statements and Exhibits under Item 9.01. This is a multi-item mandatory filing for a material event, but specific details on the agreement, transaction value, financial impacts, or other quantitative data are NOT_DISCLOSED in the provided summary. Sector is not specified.
29-12-2025
Silo Pharma, Inc. filed a Form 8-K on December 29, 2025 (AccNo: 0001213900-25-125838, Size: 191 KB), reporting under Item 3.01 a Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. No additional details on the delisting reason, financial impacts, or transaction values are disclosed in the provided information. This is a material negative event signaling potential exchange delisting.
29-12-2025
Azenta, Inc. filed a Form 8-K on December 29, 2025 (AccNo: 0001437749-25-038787, Size: 507 KB), reporting under Item 1.01 Entry into a Material Definitive Agreement, Item 7.01 Regulation FD Disclosure, and Item 9.01 Financial Statements and Exhibits. No specific details on the agreement, disclosure content, transaction value, or financial impacts are provided in the filing summary. Sector not specified.
29-12-2025
Company filed an 8-K on December 29, 2025 (AccNo: 0001304280-25-000058, Size: 135 KB) reporting under Item 1.01 Entry into a Material Definitive Agreement and Item 9.01 Financial Statements and Exhibits. Event classified as Material Event from US SEC source. No details on the agreement, parties, value, or financial impacts disclosed.
29-12-2025
An unnamed company filed a Form 8-K on December 29, 2025 (AccNo: 0001661306-25-000098, Size: 284 KB), reporting under Item 1.01 entry into a Material Definitive Agreement and under Item 9.01 Financial Statements and Exhibits. No details on the agreement, parties, transaction value, strategic importance, or financial impacts are disclosed in the provided filing summary. Sector is not specified.
29-12-2025
Village Super Market Inc filed a Form 8-K on December 29, 2025 (AccNo: 0000103595-25-000024, size 23 MB), reporting entry into a material definitive agreement under Item 1.01 and creation of a direct financial obligation or off-balance sheet arrangement under Item 2.03, with financial statements and exhibits under Item 9.01. No specific details on the agreement, transaction value, parties involved, or financial impacts are disclosed in the provided information. This is a multi-item mandatory filing as a material event.
29-12-2025
Momentus Inc. filed a Form 8-K on December 29, 2025 (AccNo: 0001140361-25-046720, Size: 227 KB), reporting Item 1.01 (Entry into a Material Definitive Agreement), Item 2.03 (Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement), Item 3.03 (Material Modifications to Rights of Security Holders), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item mandatory filing as a material event. No specific transaction details, dollar values, parties, or financial metrics are disclosed in the provided filing summary.
29-12-2025
CIRTRAN CORP filed a Form 8-K on December 29, 2025 (AccNo: 0001493152-25-029335, Size: 5 MB), reporting under Item 1.01 Entry into a Material Definitive Agreement and Item 9.01 Financial Statements and Exhibits. Sector not specified. No specific details on the agreement, transaction value, or exhibits provided in the summary.
29-12-2025
Vivakor, Inc. filed a Form 8-K on December 29, 2025 (AccNo: 0001829126-25-010328, Size: 193 KB) reporting Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. This discloses a delisting event from the US market. No further details on reasons, financial impacts, or transaction values are provided.
29-12-2025
Company filed an 8-K on 2025-12-29 (AccNo: 0001539497-25-003348, Size: 6 MB) reporting under Item 1.01 entry into a Material Definitive Agreement and under Item 9.01 Financial Statements and Exhibits. Event Type: Material Event, Date: December 29, 2025, Source: us_sec. Sector not specified; no details on agreement parties, terms, or financial impact provided.
29-12-2025
AAON, INC. filed a Form 8-K on December 29, 2025 (AccNo: 0000824142-25-000205, Size: 262 KB), reporting Item 1.01 (Entry into a Material Definitive Agreement), Item 2.03 (Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item mandatory disclosure with no specific details on the agreement, transaction value, counterparties, or financial impacts provided in the summary. All quantitative data, named entities beyond the filer, and strategic context are NOT_DISCLOSED.
29-12-2025
Genasys Inc. filed a Form 8-K on December 29, 2025 (AccNo: 0001193125-25-335297), reporting under Item 1.01 (Entry into a Material Definitive Agreement), Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers), and Item 7.01 (Regulation FD Disclosure). This is a multi-item filing with no specific details on the agreement, personnel changes, or disclosures provided in the available information. All transaction values, financial metrics, and other quantitative data are NOT_DISCLOSED.
29-12-2025
The company filed a Form 8-K on December 29, 2025 (AccNo: 0001193125-25-335302, Size: 880 KB), disclosing under Item 1.01 entry into a material definitive agreement and under Item 2.03 creation of a direct financial obligation or an obligation under an off-balance sheet arrangement. Item 9.01 references financial statements and exhibits. No specific details on the transaction, parties, dollar values, or terms are provided in the filing summary.
29-12-2025
Shuttle Pharmaceuticals Holdings, Inc. filed a Form 8-K on December 29, 2025 (AccNo: 0001493152-25-029361), reporting under Item 1.01 entry into a material definitive agreement, Item 3.02 unregistered sales of equity securities, and Item 9.01 financial statements and exhibits. No specific transaction details, dollar values, share counts, or other quantitative data are disclosed in the provided filing summary. This is a multi-item mandatory disclosure as a material event.
29-12-2025
Cartesian Growth Corp II filed a Form 8-K on December 29, 2025 (AccNo: 0001104659-25-124838, Size: 224 KB), reporting under Item 1.01 entry into a material definitive agreement, under Item 2.03 creation of a direct financial obligation or obligation under an off-balance sheet arrangement, and under Item 9.01 financial statements and exhibits. This is a multi-item mandatory filing as a material event. No specific transaction details, dollar values, parties, or financial metrics are disclosed in the provided information.
29-12-2025
Dermata Therapeutics, Inc. filed a Form 8-K on 2025-12-29 (AccNo: 0001493152-25-029364, Size: 1 MB) disclosing Items 1.01 (Entry into a Material Definitive Agreement), 3.02 (Unregistered Sales of Equity Securities), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). This is a multi-item mandatory filing for material events, but specific details, transaction values, or financial impacts are NOT_DISCLOSED in the provided summary. Sector not specified.
29-12-2025
TeraWulf Inc. filed a Form 8-K on December 29, 2025 (AccNo: 0001104659-25-124839, Size: 1 MB), reporting under Item 1.01 (Entry into a Material Definitive Agreement), Item 2.03 (Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement), and Item 9.01 (Financial Statements and Exhibits). No specific details on the agreement, transaction value, parties involved, or financial impacts are disclosed in the provided information. This is a multi-item mandatory filing as a material event.
29-12-2025
PTC Therapeutics, Inc. filed a Form 8-K on December 29, 2025 (AccNo: 0001104659-25-124837, size: 156 KB), reporting under Item 1.01 entry into a Material Definitive Agreement. No details on the agreement's nature, counterparties, financial terms, or strategic context are disclosed in the provided summary. This is a single-item mandatory filing with sector unspecified.
29-12-2025
Fly-E Group, Inc. filed a Form 8-K on December 29, 2025 (AccNo: 0001213900-25-126038, Size: 192 KB), reporting under Item 3.01 a Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. No specific details on the delisting reason, transaction value, financial impacts, or other quantitative data are disclosed. Sector is not specified.
29-12-2025
Envoy Medical, Inc. filed a Form 8-K on December 29, 2025 (AccNo: 0001213900-25-126032, Size: 277 KB), reporting under Item 1.01 entry into a Material Definitive Agreement and under Item 9.01 Financial Statements and Exhibits. No details on the agreement, transaction value, parties involved, or financial impacts are disclosed in the provided summary. Sector not specified.
29-12-2025
Maui Land & Pineapple Co Inc filed a Form 8-K on December 29, 2025 (AccNo: 0001437749-25-038852, Size: 152 KB), reporting under Item 1.01 entry into a material definitive agreement. No further details on the agreement, transaction value, parties, or financial terms are disclosed in the provided information. Sector not specified.
29-12-2025
UWM Holdings Corp filed a Form 8-K on December 29, 2025 (AccNo: 0001783398-25-000070, size: 182 KB), reporting under Item 3.01 a Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. No additional details on the reasons for delisting, financial impacts, transaction values, or other quantitative metrics are provided in the filing summary. Sector is not specified.
29-12-2025
IMAC Holdings, Inc. filed a Form 8-K on December 29, 2025 (AccNo: 0001493152-25-029352, Size: 204 KB), reporting Item 1.01 (Entry into a Material Definitive Agreement), Item 2.03 (Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement), and Item 9.01 (Financial Statements and Exhibits). No specific details on the agreement, transaction value, parties involved, or financial terms are disclosed in the provided summary. This is a multi-item mandatory filing as a material event.
29-12-2025
Modine Manufacturing Co. filed a Form 8-K on December 29, 2025 (AccNo: 0001104659-25-124872, Size: 310 KB) reporting entry into a material definitive agreement under Item 1.01 and financial statements and exhibits under Item 9.01. No details on the agreement's nature, parties, terms, dollar value, or financial impacts are disclosed in the provided information. Sector is not specified.
29-12-2025
Dyadic International Inc filed a Form 8-K on December 29, 2025 (AccNo: 0001493152-25-029351, Size: 233 KB), reporting under Item 1.01 the entry into a Material Definitive Agreement and under Item 9.01 providing Financial Statements and Exhibits. No details on the agreement's parties, terms, value, or financial impact are disclosed in the provided information. This is a multi-item mandatory filing signaling a significant undisclosed corporate event.
29-12-2025
Faraday Future Intelligent Electric Inc. filed a Form 8-K on December 29, 2025 (AccNo: 0001213900-25-126069, Size: 341 KB), reporting multiple items including Entry into a Material Definitive Agreement (Item 1.01), Unregistered Sales of Equity Securities (Item 3.02), Material Modifications to Rights of Security Holders (Item 3.03), Amendments to Articles of Incorporation or Bylaws (Item 5.03), and Financial Statements and Exhibits (Item 9.01). This is a multi-item mandatory filing as a material event, but no specific details on transactions, values, or impacts are provided in the summary. Sector not specified.
29-12-2025
Hyperfine, Inc. filed a Form 8-K on December 29, 2025 (AccNo: 0001193125-25-335370, Size: 434 KB), reporting Item 1.01 (Entry into a Material Definitive Agreement), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). No specific details on the agreement, events, transaction value, or financial impacts are disclosed in the provided summary. This is a multi-item mandatory filing under SEC 8-K requirements.
29-12-2025
TEN Holdings, Inc. filed a Form 8-K on December 29, 2025 (AccNo: 0001493152-25-029370, Size: 1 MB), reporting multiple items including entry into a material definitive agreement (Item 1.01), unregistered sales of equity securities (Item 3.02), departures/elections/appointments of directors/officers and compensatory arrangements (Item 5.02), Regulation FD disclosure (Item 7.01), and financial statements/exhibits (Item 9.01). This is a multi-item filing with no specific transaction values, share counts, dollar amounts, named entities, or financial impacts disclosed in the provided summary. Sector is not specified.
29-12-2025
ModivCare Inc filed an 8-K on 2025-12-29 (AccNo: 0001437749-25-038831, Size: 9 MB) reporting bankruptcy or receivership under Item 1.03, alongside entry into (1.01) and termination of (1.02) material definitive agreements, completion of asset disposition (2.01), material modifications to security holders' rights (3.03), changes in control (5.01), director/officer changes (5.02), and Regulation FD disclosure (7.01). This multi-item filing signals severe financial distress and restructuring. No transaction values, financial metrics, or other quantitative details are disclosed.
29-12-2025
ARTS WAY MANUFACTURING CO INC filed a Form 8-K on December 29, 2025 (AccNo: 0001437749-25-038843, Size: 261 KB) reporting under Item 1.01 entry into a Material Definitive Agreement and under Item 9.01 Financial Statements and Exhibits. No details on the nature of the agreement, counterparties, transaction value, or financial impacts are disclosed in the provided information. Sector is not specified.
29-12-2025
Company filed Form 8-K on 2025-12-29 (AccNo: 0001193125-25-335361) reporting under Item 1.01 (Entry into a Material Definitive Agreement), Item 2.03 (Creation of a Direct Financial Obligation or Off-Balance Sheet Arrangement), Item 3.02 (Unregistered Sales of Equity Securities), and Item 9.01 (Financial Statements and Exhibits). Event occurred on December 29, 2025. No specific transaction details, dollar values, parties, or financial metrics disclosed in the provided information.
29-12-2025
ScanTech AI Systems Inc. filed an 8-K on December 29, 2025 (AccNo: 0001104659-25-124882, Size: 393 KB), reporting under Item 1.01 entry into a material definitive agreement, Item 2.03 creation of a direct financial obligation or off-balance sheet arrangement, and Item 3.02 unregistered sales of equity securities, with Item 9.01 for financial statements and exhibits. This multi-item filing indicates a significant transaction but provides no details on parties, terms, or values. Sector not specified.
29-12-2025
Abacus Global Management, Inc. filed a Form 8-K on December 29, 2025 (AccNo: 0001628280-25-059007, Size: 195 KB), reporting under Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Item 8.01 Other Events, and Item 9.01 Financial Statements and Exhibits. This is a multi-item mandatory filing indicating a delisting event from the US market. No specific details on delisting reasons, financial impacts, transaction values, or sector provided.
29-12-2025
Bitcoin Depot Inc. filed a Form 8-K on December 29, 2025 (AccNo: 0001193125-25-335377, Size: 2 MB), reporting under Item 1.01 (Entry into a Material Definitive Agreement), Item 2.03 (Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing indicating a significant agreement and financial commitment, but core event details, transaction value, and impacts are NOT_DISCLOSED in the provided summary. Sector is not specified.
29-12-2025
Ellington Financial Inc. filed a Form 8-K on December 29, 2025 (AccNo: 0001628280-25-059006, Size: 638 KB), reporting Item 1.01 Entry into a Material Definitive Agreement and Item 9.01 Financial Statements and Exhibits. No specific details on the agreement, transaction size, parties involved, or financial impacts are disclosed in the provided filing summary. Sector is not specified.
29-12-2025
Coupang, Inc. filed a Form 8-K on December 29, 2025 (AccNo: 0001834584-25-000202), reporting a material cybersecurity incident under Item 1.05, Regulation FD Disclosure under Item 7.01, and Financial Statements and Exhibits under Item 9.01. This is a multi-item filing indicating a potentially significant cybersecurity event with no specific details on the incident's nature, scope, financial impact, or remediation provided in the available summary. No quantitative data such as costs, affected users, or revenue impacts is disclosed.
29-12-2025
Organogenesis Holdings Inc. filed an 8-K on December 29, 2025 (AccNo: 0001193125-25-335425, size 219 KB), reporting under Item 1.01 entry into a Material Definitive Agreement and under Item 9.01 financial statements and exhibits. No details on the agreement, transaction value, or financial impacts are disclosed in the provided summary. Sector not specified.
29-12-2025
INNO HOLDINGS INC. filed a Form 8-K on December 29, 2025 (AccNo: 0001493152-25-029388, Size: 445 KB), reporting under Item 1.01 entry into a Material Definitive Agreement. Item 9.01 discloses Financial Statements and Exhibits. No details on the agreement, transaction value, or financial impacts are provided in the summary.
29-12-2025
Algorhythm Holdings, Inc. filed a Form 8-K on December 29, 2025 (AccNo: 0001493152-25-029389), disclosing under Item 1.01 entry into a material definitive agreement, Item 2.03 creation of a direct financial obligation or off-balance sheet arrangement, Item 3.02 unregistered sales of equity securities, and Item 9.01 financial statements and exhibits. This is a multi-item mandatory filing with no specific transaction details, dollar values, parties, or quantitative impacts provided in the summary. Sector is not specified.
29-12-2025
Birchtech Corp. filed a Form 8-K on December 29, 2025 (AccNo: 0001477932-25-009214, Size: 159 KB), reporting under Item 3.03 material modifications to rights of security holders, Item 5.03 amendments to articles of incorporation or bylaws or change in fiscal year, and Item 9.01 financial statements and exhibits. No specific details on the nature, scope, or impacts of these changes are disclosed in the provided summary. Sector is not specified.
29-12-2025
Noodles & Company filed a Form 8-K on December 29, 2025 (AccNo: 0001275158-25-000116, Size: 152 KB) reporting under Item 3.01 a Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. This indicates a delisting event from the US market. No further details on reasons, financial impacts, transaction values, or other specifics are disclosed.
29-12-2025
Arcadia Biosciences, Inc. filed a Form 8-K on December 29, 2025 (AccNo: 0001193125-25-335410, Size: 220 KB), disclosing under Item 1.02 the termination of a material definitive agreement, Item 7.01 Regulation FD Disclosure, and Item 9.01 Financial Statements and Exhibits. No specific details on the terminated agreement, transaction value, financial impacts, or other quantitative data are provided in the filing summary. This is a multi-item mandatory filing related to a material event.
29-12-2025
Tonix Pharmaceuticals Holding Corp. filed a Form 8-K on December 29, 2025 (AccNo: 0001999371-25-021283, Size: 850 KB), disclosing under Item 1.01 entry into a material definitive agreement, Item 8.01 other events, and Item 9.01 financial statements and exhibits. No specific details on the agreement, events, transaction values, or financial impacts are provided in the filing summary. Sector not specified.
29-12-2025
Company filed Form 8-K on December 29, 2025 (AccNo: 0000038723-25-000149, Size: 251 KB) reporting Item 1.01 (Entry into a Material Definitive Agreement), Item 2.03 (Creation of a Direct Financial Obligation or Off-Balance Sheet Arrangement), and Item 9.01 (Financial Statements and Exhibits). Event dated December 29, 2025. No details on transaction parties, value, terms, or financial metrics provided.
29-12-2025
MDU Resources Group Inc filed a Form 8-K on December 29, 2025 (AccNo: 0001539497-25-003350, size 999 KB), reporting Item 1.01 (Entry into a Material Definitive Agreement), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). No specific details on the agreement, events, transaction values, or financial impacts are disclosed in the provided filing summary. Sector is not specified.
29-12-2025
CEA Industries Inc. filed a Form 8-K on December 29, 2025 (AccNo: 0001493152-25-029421, Size: 321 KB), reporting multiple material events under Items 1.01 (Entry into a Material Definitive Agreement), 3.03 (Material Modifications to Rights of Security Holders), 5.03 (Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). This is a multi-item mandatory filing with no specific details on transactions, values, or impacts provided in the summary. Sector is not specified.
29-12-2025
Perimeter Solutions, Inc. filed a Form 8-K on December 29, 2025 (AccNo: 0001493152-25-029414, Size: 2 MB), reporting Item 1.01 (Entry into a Material Definitive Agreement), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing indicating a material definitive agreement and other events, but specific details including transaction value, counterparties, financial impacts, or dollar amounts are NOT_DISCLOSED. No quantitative financial metrics, share counts, or percentages are mentioned.
29-12-2025
Verses AI Inc. filed a Form 8-K on 2025-12-29 (AccNo: 0001493152-25-029451, Size: 571 KB) reporting multiple items: 1.01 (Entry into a Material Definitive Agreement), 2.03 (Creation of a Direct Financial Obligation or Off-Balance Sheet Arrangement), 3.02 (Unregistered Sales of Equity Securities), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). This is a multi-item mandatory filing as a material event, but specific details on transactions, values, counterparties, or impacts are NOT_DISCLOSED.
29-12-2025
Boxlight Corp filed a Form 8-K on December 29, 2025 (AccNo: 0001104659-25-124917, Size: 1 MB), reporting under Item 1.01 (Entry into a Material Definitive Agreement), Item 2.03 (Creation of a Direct Financial Obligation or Off-Balance Sheet Arrangement), Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific details on transaction value, parties, dollar amounts, or financial impacts disclosed in the provided summary. Sector is not specified.
29-12-2025
BiomX Inc. filed a Form 8-K on December 29, 2025 (AccNo: 0001213900-25-126161, Size: 1 MB), reporting Item 1.01 Entry into a Material Definitive Agreement, Item 3.02 Unregistered Sales of Equity Securities, and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing with no specific transaction details, values, parties, or financial metrics disclosed in the provided information. Sector not specified.
29-12-2025
CACI International Inc./DE/ filed a Form 8-K on December 29, 2025 (AccNo: 0001628280-25-059047, Size: 891 KB), reporting Item 1.01 (Entry into a Material Definitive Agreement), Item 2.03 (Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement), and Item 9.01 (Financial Statements and Exhibits). No specific details on the agreement, transaction value, counterparties, or financial impacts are disclosed in the provided filing summary. Sector not specified.
Get daily alerts with 5 investment signals, 4 risk alerts, 4 opportunities and full AI analysis of all 76 filings
🇺🇸 More from United States
View all →March 25, 2026
US Pre-Market SEC Filings Roundup — March 25, 2026
US Pre-Market SEC Filings Roundup
March 24, 2026
US Merger & Acquisition SEC Filings — March 24, 2026
US Merger & Acquisition SEC Filings
March 24, 2026
US Corporate Board Director Changes SEC Filings — March 24, 2026
US Corporate Board Director Changes SEC Filings
March 24, 2026
US Executive Officer Management Changes SEC — March 24, 2026
US Executive Officer Management Changes SEC